Table of Content

1. Research Scope & Methodology
1.1. Study Objectives
1.2. Scope Of Study
1.3. Methodology
1.4. Assumptions & Limitations

2. Executive Summary
2.1. Market Size & Estimates
2.2. Market Overview

3. Market Dynamics
3.1. Market Definition
3.2. Key Drivers
3.2.1. Widespread Acceptance Of Immunoglobulin-Based Therapies
3.2.2. Growing Usage Of Albumin In Other Therapeutic Areas
3.2.3. Growing Geriatric Population
3.2.4. Rising Prevalence Of Alpha-1 Antitrypsin Deficiency (Aatd)
3.2.5. Increase In The Patient Pool For Hemophilia Treatment
3.2.6. Rise In Occurrence Of Sports Injuries
3.3. Key Restraints
3.3.1. Increasing Usage Of Recombinant Plasma Products In Therapeutic Treatments
3.3.2. High Costs Of Blood Plasma Treatments
3.3.3. Adverse Reactions Associated With Post-Transfusion
3.3.4. Spread Of Pathogenic Contaminants
3.3.5. High Regulations In The Market

4. Key Analytics
4.1. Porter’S Five Forces Analysis
4.1.1. Threat Of New Entry
4.1.2. Threat Of Substitution
4.1.3. Buyer’S Power
4.1.4. Supplier’S Power
4.1.5. Competitive Rivalry
4.2. Plasma Therapeutics Regulation
4.3. Clinical Guidelines
4.4. Opportunity Matrix
4.5. Vendor Landscape
4.6. Key Investment Insights

5. Market By Mode Of Delivery
5.1. Infusion Solutions
5.2. Gels
5.3. Sprays
5.4. Biomedical Sealants

6. Market By Disorder
6.1. Immunodeficiency Disease
6.2. Hypogammaglobulinemia
6.3. Hemophilia
6.4. Von Willebrand Disease (Vwd)
6.5. Other Disorders

7. Market By Blood Plasma Derivatives
7.1. Immunoglobulin
7.1.1. Intravenous Immunoglobulin
7.1.2. Subcutaneous Immunoglobulin
7.1.3. Other Immunoglobulin Types
7.2. Albumin
7.3. Hyperimmune
7.4. Coagulation Factor Concentrates
7.5. Other Plasma Fractionation Products

8. Market By Therapeutic Indication
8.1. Neurology
8.2. Immunology
8.3. Oncology
8.4. Transplantation
8.5. Hematology
8.6. Rheumatology
8.7. Pulmonology
8.8. Other Therapeutic Indication

9. Market By End-User
9.1. Hospitals And Clinics
9.2. Research Laboratories
9.3. Academic Institutions

10. Geographical Analysis
10.1. North America
10.1.1. The United States
10.1.2. Canada
10.2. Europe
10.2.1. The United Kingdom
10.2.2. Germany
10.2.3. France
10.2.4. Italy
10.2.5. Russia
10.2.6. Belgium
10.2.7. Poland
10.2.8. Rest Of Europe
10.3. Asia Pacific
10.3.1. Japan
10.3.2. China
10.3.3. Australia & New Zealand
10.3.4. India
10.3.5. South Korea
10.3.6. Thailand
10.3.7. Indonesia
10.3.8. Vietnam
10.3.9. Rest Of Asia Pacific
10.4. Rest Of World
10.4.1. Latin America
10.4.2. Middle East & Africa

11. Company Profiles
11.1. Adma Biologics
11.2. Arthrex
11.3. Bio Products Laboratory
11.4. Baxter International
11.5. Biotest Ag
11.6. Cerus Corporation (Cerus)
11.7. China Biologic Products
11.8. Csl Limited
11.9. Fusion Health Care
11.10. Green Cross Holdings Corporation
11.11. Grifols
11.12. Lfb
11.13. Octapharma
11.14. Takeda Pharmaceutical Company
11.15. Kedrion Biopharma Inc



List of Figures


Figure 1: Porter’S Five Force Analysis
Figure 2: Opportunity Matrix
Figure 3: Vendor Landscape
Figure 4: Key Investment Insights
Figure 5: Immunoglobulin Infusions Side Effects
Figure 6: Role Of Fibrin Sealant In Coagulation Cascade
Figure 7: Global Blood Plasma Market, By Disorder, In 2019
Figure 8: Global Blood Plasma Market, By Immunodeficiency Disease, 2020-2028 (In $ Million)
Figure 9: Global Blood Plasma Market, By Hypogammaglobulinemia, 2020-2028 (In $ Million)
Figure 10: Global Blood Plasma Market, By Hemophilia, 2020-2028 (In $ Million)
Figure 11: Global Blood Plasma Market, By Von Willebrand Disease (Vwd), 2020-2028 (In $ Million)
Figure 12: Global Blood Plasma Market, By Other Disorders, 2020-2028 (In $ Million)
Figure 13: Global Blood Plasma Market, By Blood Derivatives, In 2019
Figure 14: Global Blood Plasma Market, By Immunoglobulin, 2020-2028 (In $ Million)
Figure 15: Global Immunoglobulin Market, By Intravenous Immunoglobulin, 2020-2028 (In $ Million)
Figure 16: Global Immunoglobulin Market, By Subcutaneous Immunoglobulin, 2020-2028 (In $ Million)
Figure 17: Global Immunoglobulin Market, By Other Immunoglobulin Types, 2020-2028 (In $ Million)
Figure 18: Global Blood Plasma Market, By Albumin, 2020-2028 (In $ Million)
Figure 19: Global Blood Plasma Market, By Hyperimmune, 2020-2028 (In $ Million)
Figure 20: Hyperimmunes Isolation Process
Figure 21: Global Blood Plasma Market, By Coagulation Factor Concentrates, 2020-2028 (In $ Million)
Figure 22: Global Blood Plasma Market, By Other Plasma Fractionation Products, 2020-2028 (In $ Million)
Figure 23: Global Blood Plasma Market, By Therapeutic Indication, In 2019
Figure 24: Global Blood Plasma Market, By Neurology, 2020-2028 (In $ Million)
Figure 25: Global Blood Plasma Market, By Immunology, 2020-2028 (In $ Million)
Figure 26: Global Blood Plasma Market, By Oncology, 2020-2028 (In $ Million)
Figure 27: Global Blood Plasma Market, By Transplantation, 2020-2028 (In $ Million)
Figure 28: Global Blood Plasma Market, By Hematology, 2020-2028 (In $ Million)
Figure 29: Global Blood Plasma Market, By Rheumatology, 2020-2028 (In $ Million)
Figure 30: Lupus Infection Symptoms
Figure 31: Global Blood Plasma Market, By Pulmonology, 2020-2028 (In $ Million)
Figure 32: Global Blood Plasma Market, By Other Therapeutic Indication, 2020-2028 (In $ Million)
Figure 33: Global Blood Plasma Market, By End-User, In 2019
Figure 34: Global Blood Plasma Market, By Hospitals And Clinics, 2020-2028 (In $ Million)
Figure 35: Global Blood Plasma Market, By Research Laboratories, 2020-2028 (In $ Million)
Figure 36: Global Blood Plasma Market, By Academic Institutions, 2020-2028 (In $ Million)
Figure 37: North America Blood Plasma Market, Country Outlook, 2019 & 2028 (In %)
Figure 38: The United States Blood Plasma Market, 2020-2028 (In $ Million)
Figure 39: Canada Blood Plasma Market, 2020-2028 (In $ Million)
Figure 40: Europe Blood Plasma Market, Regional Outlook, 2019 & 2028 (In %)
Figure 41: The United Kingdom Blood Plasma Market, 2020-2028 (In $ Million)
Figure 42: Germany Blood Plasma Market, 2020-2028 (In $ Million)
Figure 43: France Blood Plasma Market, 2020-2028 (In $ Million)
Figure 44: Italy Blood Plasma Market, 2020-2028 (In $ Million)
Figure 45: Russia Blood Plasma Market, 2020-2028 (In $ Million)
Figure 46: Belgium Blood Plasma Market, 2020-2028 (In $ Million)
Figure 47: Poland Blood Plasma Market, 2020-2028 (In $ Million)
Figure 48: Rest Of Europe Blood Plasma Market, 2020-2028 (In $ Million)
Figure 49: Asia Pacific Blood Plasma Market, Country Outlook, 2019 & 2028 (In %)
Figure 50: Japan Blood Plasma, 2020-2028 (In $ Million)
Figure 51: China Blood Plasma, 2020-2028 (In $ Million)
Figure 52: Australia & New Zealand Blood Plasma, 2020-2028 (In $ Million)
Figure 53: India Blood Plasma, 2020-2028 (In $ Million)
Figure 54: South Korea Blood Plasma Market, 2020-2028 (In $ Million)
Figure 55: Thailand Blood Plasma Market, 2020-2028 (In $ Million)
Figure 56: Indonesia Blood Plasma Market, 2020-2028 (In $ Million)
Figure 57: Vietnam Blood Plasma Market, 2020-2028 (In $ Million)
Figure 58: Rest Of Asia Pacific Blood Plasma Market, 2020-2028 (In $ Million)
Figure 59: Rest Of World Blood Plasma Market, Regional Outlook, 2019 & 2028 (In %)
Figure 60: Latin America Blood Plasma Market, 2020-2028 (In $ Million)
Figure 61: Middle East & Africa Blood Plasma Market, 2020-2028 (In $ Million)


List of Tables


List of Tables


TABLE 1: MARKET SNAPSHOT - BLOOD PLASMA
TABLE 2: GLOBAL BLOOD PLASMA MARKET, BY DISORDER, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 3: GLOBAL BLOOD PLASMA MARKET, BY DISORDER, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 4: GLOBAL IMMUNODEFICIENCY DISEASES MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 5: GLOBAL IMMUNODEFICIENCY DISEASES MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 6: GLOBAL HYPOGAMMAGLOBULINEMIA MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 7: GLOBAL HYPOGAMMAGLOBULINEMIA MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 8: GLOBAL HEMOPHILIA MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 9: GLOBAL HEMOPHILIA MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 10: GLOBAL VON WILLEBRAND DISEASE (VWD) MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 11: GLOBAL VON WILLEBRAND DISEASE (VWD) MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 12: GLOBAL OTHER DISORDERS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 13: GLOBAL OTHER DISORDERS MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 14: GLOBAL BLOOD PLASMA MARKET, BY BLOOD DERIVATIVES, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 15: GLOBAL BLOOD PLASMA MARKET, BY BLOOD DERIVATIVES, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 16: GLOBAL IMMUNOGLOBULIN MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 17: GLOBAL IMMUNOGLOBULIN MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 18: GLOBAL IMMUNOGLOBULIN MARKET, BY TYPE, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 19: GLOBAL IMMUNOGLOBULIN MARKET, BY TYPE, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 20: GLOBAL INTRAVENOUS IMMUNOGLOBULIN MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 21: GLOBAL INTRAVENOUS IMMUNOGLOBULIN MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 22: GLOBAL SUBCUTANEOUS IMMUNOGLOBULIN MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 23: GLOBAL SUBCUTANEOUS IMMUNOGLOBULIN MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 24: GLOBAL OTHER IMMUNOGLOBULIN TYPE MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 25: GLOBAL OTHER IMMUNOGLOBULIN TYPE MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 26: GLOBAL ALBUMIN MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 27: GLOBAL ALBUMIN MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 28: GLOBAL HYPERIMMUNE MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 29: GLOBAL HYPERIMMUNE MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 30: GLOBAL COAGULATION FACTOR CONCENTRATES MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 31: GLOBAL COAGULATION FACTOR CONCENTRATES MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 32: GLOBAL OTHER PLASMA FRACTIONATION PRODUCTS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 33: GLOBAL OTHER PLASMA FRACTIONATION PRODUCTS MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 34: GLOBAL BLOOD PLASMA MARKET, BY THERAPEUTIC INDICATION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 35: GLOBAL BLOOD PLASMA MARKET, BY THERAPEUTIC INDICATION, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 36: GLOBAL NEUROLOGY MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 37: GLOBAL NEUROLOGY MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 38: GLOBAL IMMUNOLOGY MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 39: GLOBAL IMMUNOLOGY MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 40: GLOBAL ONCOLOGY MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 41: GLOBAL ONCOLOGY MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 42: GLOBAL TRANSPLANTATION MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 43: GLOBAL TRANSPLANTATION MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 44: GLOBAL HEMATOLOGY MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 45: GLOBAL HEMATOLOGY MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 46: GLOBAL RHEUMATOLOGY MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 47: GLOBAL RHEUMATOLOGY MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 48: GLOBAL PULMONOLOGY MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 49: GLOBAL PULMONOLOGY MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 50: GLOBAL OTHER THERAPEUTIC INDICATION MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 51: GLOBAL OTHER THERAPEUTIC INDICATION MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 52: GLOBAL BLOOD PLASMA MARKET, BY END-USER, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 53: GLOBAL BLOOD PLASMA MARKET, BY END-USER, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 54: GLOBAL HOSPITALS AND CLINICS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 55: GLOBAL HOSPITALS AND CLINICS MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 56: GLOBAL RESEARCH LABORATORIES MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 57: GLOBAL RESEARCH LABORATORIES MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 58: GLOBAL ACADEMIC INSTITUTIONS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 59: GLOBAL ACADEMIC INSTITUTIONS MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 60: GLOBAL BLOOD PLASMA MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 61: GLOBAL BLOOD PLASMA MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 62: NORTH AMERICA BLOOD PLASMA MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 63: NORTH AMERICA BLOOD PLASMA MARKET, BY COUNTRY, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 64: EUROPE BLOOD PLASMA MARKET, BY COUNTRY, HISTORICAL YEARS 2016-2019 (IN $ MILLION)
TABLE 65: EUROPE BLOOD PLASMA MARKET, BY COUNTRY, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 66: ASIA PACIFIC BLOOD PLASMA, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 67: ASIA PACIFIC BLOOD PLASMA, BY COUNTRY, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 68: REST OF BLOOD PLASMA MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 69: REST OF BLOOD PLASMA MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)